MANAGEMENT OF HELLP SYNDROME BEFORE DELIVERY: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/d6c4mb55Keywords:
HELLP, proteinuria, hypertensionAbstract
Background: HELLP syndrome, named for 3 features of the disease (hemolysis, elevated liver enzyme levels, and low platelet levels), is a life-threatening condition that can potentially complicate pregnancy. HELLP was once known as edema-proteinuria-hypertension gestosis type B in the early 20th century and was later renamed in 1982 by Louis Weinstein.
The aim: This study aims to show management of HELLP syndrome before delivery.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search on SagePub brought up 110 articles. The results of the search conducted for the last year of 2013 yielded a total 23 articles for PubMed and 75 articles for SagePub. The result from title screening, a total 8 articles for PubMed and 28 articles for SagePub. In the end, we compiled a total of 10 papers. We included five research that met the criteria.
Conclusion: HELLP syndrome is an important complications in pregnancy which increases maternal and fetal mortality. This disease usually remits with supportive treatment which includes prescription of corticosteroid, magnesium sulfate, stabilization of mother and pregnancy termination. Plasmapheresis is a treatment of choice which improves clinical outcomes in complicated cases.
References
Nakakita B, Ueda A, Chigusa Y, Mogami H, Mandai M, Kondoh E. Modified Mississippi protocol for HELLP/partial HELLP syndrome occurring in the periviable period: A report of three cases. Hypertens Res Pregnancy. 2020;8(1):22–5.
Khalid F, Mahendraker N, Tonismae T. Pathophysiology. 2023;1–8.
Lam M, Dierking E. Intensive Care Unit issues in eclampsia and HELLP syndrome. Int J Crit Illn Inj Sci. 2017;7(3):136–41.
Bernardes TP, Zwertbroek EF, Broekhuijsen K, Koopmans C, Boers K, Owens M, et al. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis. Ultrasound Obstet Gynecol. 2019;53(4):443–53.
Sungkar A, Irwinda R, Surya R, Kurniawan AP. Maternal Characteristics, Pregnancy, and Neonatal Outome in Preeclampsia and HELLP Syndrome: a Comparative Study. eJournal Kedokt Indones. 2021;9(1):7.
Hosten AK, Bonitz J, Thäle V, Tchirikov M. Prolongation of Pregnancy in Patients with HELLP Syndrome Using Methylprednisolone: A Retrospective Multicentric Analysis. Life. 2023;13(4):1–13.
Li B, Yang H. Comparison of clinical features and pregnancy outcomes in early- and late-onset preeclampsia with HELLP syndrome: a 10-year retrospective study from a tertiary hospital and referral center in China. BMC Pregnancy Childbirth [Internet]. 2022;22(1):1–10. Available from: https://doi.org/10.1186/s12884-022-04466-9
Cadoret F, Guerby P, Cavaignac-Vitalis M, Vayssiere C, Parant O, Vidal F. Expectant management in HELLP syndrome: predictive factors of disease evolution. J Matern Neonatal Med [Internet]. 2021;34(24):4029–34. Available from: https://doi.org/10.1080/14767058.2019.1702956
Rimaitis K, Grauslyte L, Zavackiene A, Baliuliene V, Nadisauskiene R, Macas A. Diagnosis of HELLP syndrome: A 10-year survey in a perinatology centre. Int J Environ Res Public Health. 2019;16(1):1–9.
Vafaeimanesh J, Nazari A, Hosseinzadeh F. Plasmapheresis: Lifesaving treatment in severe cases of HELLP syndrome. Casp J Intern Med. 2014;5(4):243–7.
Petca A, Miron BC, Pacu I, Dumitrașcu MC, Mehedințu C, Șandru F, et al. HELLP Syndrome—Holistic Insight into Pathophysiology. Med. 2022;58(2):1–14.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
